We’d like to hear your comments about this interesting article. Should there be parity in the costs of oral vs. intravenous drugs for cancer treatments?
Dr. Hildreth is a medical oncologist in private practice and has his own blog. Making Headway doesn’t know Dr. Hildreth. We just found this article compelling.